Catheter Precision, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

VTAK$0.15-0.7%Stored close · as of Oct 2, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

	June 30, 2026	December 31, 2025
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents	$643	$88
Marketable securities	1,196	—
Accounts receivable, net	120	155
Inventories	88	86
Prepaid expenses and other current assets	463	61
Total current assets	2,510	390
Property and equipment, net	128	64
Operating lease right-of-use assets, net	2,509	162
Other non-current assets	160	8
Intangible assets, net	18,601	15,236
Goodwill	12,962	—
TOTAL ASSETS	$36,870	$15,860
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable	$1,447	$1,492
Accrued expenses	1,982	1,697
Deferred revenue	145	—
Convertible notes payable, at fair value	—	298
Short-term promissory notes	1,832	—
Short-term notes payable, net of discount	5,192	—
Short-term notes payable due to related parties	401	—
Short-term notes payable of variable interest entities due to related parties	312	306
Deferred stock issuance liability	647	—
Current portion of royalties payable due to related parties	20	51
Current portion of operating lease liabilities	1,474	63
Total current liabilities	13,452	3,907
Royalties payable due to related parties	792	792
Operating lease liabilities	1,155	101
Notes payable of variable interest entities, net of discount	1,398	1,330
Notes payable due to related parties	1,828	1,748
Notes payable	63	—
Deferred tax liability	1,044	1,331
Total liabilities	19,732	9,209
Commitments and Contingencies (see Note 18)
Stockholders' Equity
Preferred Stock, $0.0001 par value, 10,000,000 shares authorized
Series B Convertible Preferred Stock, $0.0001 par value, 3,000 shares designated; 321 and 2,229 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	—	—
Series C Convertible Preferred Stock (comprising sub-series C-1 and C-2), $0.0001 par value, 7,157 shares designated; 6,940 and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	—	—
Series D Convertible Preferred Stock, $0.0001 par value, 11,028 shares designated; 11,028 and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	—	—
Series J Convertible Preferred Stock, $0.0001 par value, 9,490 shares designated; 9,490 shares issued and outstanding as of June 30, 2026 and December 31, 2025	—	—
Series X Convertible Preferred Stock, $0.0001 par value, 15,404 shares designated; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025	—	—
Common stock, $0.0001 par value, 500,000,000 shares authorized; 3,609,471 and 1,738,955 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	332,072	316,589
Accumulated deficit	(314,511)	(309,535)
Total stockholders' equity attributable to Catheter Precision, Inc.	17,561	7,054
Non-controlling interest	(423)	(403)
Total stockholders' equity	17,138	6,651
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$36,870	$15,860

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.